In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer

Detalhes bibliográficos
Autor(a) principal: Pereira, Claudia Maria
Data de Publicação: 2018
Outros Autores: de Carvalho, Ana Carolina [UNIFESP], da Silva, Felipe Rodrigues, Melendez, Matias Eliseo, Lessa, Roberta Cardim, Andrade, Valeria Cristina C. [UNIFESP], Kowalski, Luiz Paulo, Vettore, Andre L. [UNIFESP], Carvalho, Andre Lopes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/s12885-018-4077-3
https://repositorio.unifesp.br/handle/11600/54124
Resumo: Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis.
id UFSP_4f19f097c770d237331b68f64f939f37
oai_identifier_str oai:repositorio.unifesp.br/:11600/54124
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancerOSCCGene expressionMethylationCA3FHL1Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis.AC Camargo Canc Hosp, Dept Head & Neck Surg, Sao Paulo, BrazilLudwig Inst Canc Res, Lab Canc Genet, Sao Paulo, BrazilBarretos Canc Hosp, Mol Oncol Res Ctr, Barretos, BrazilEmbrapa Informat Agr, Campinas, SP, BrazilUniv Fed Sao Paulo, Discipline Hematol & Hemotherapy, UNIFESP, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Sci Biol, UNIFESP, Diadema, BrazilBarretos Canc Hosp, Dept Head & Neck Surg, Barretos, SP, BrazilUniv Fed Sao Paulo, Discipline Hematol & Hemotherapy, UNIFESP, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Sci Biol, UNIFESP, Diadema, BrazilWeb of ScienceConselho Nacional de Pesquisa (CNPq) |Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)CNPq: 476586/2006-2FAPESP: 05/02580-8Biomed Central Ltd2020-07-08T13:09:40Z2020-07-08T13:09:40Z2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.1186/s12885-018-4077-3Bmc Cancer. London, v. 18, p. -, 2018.10.1186/s12885-018-4077-3WOS000425517300002.pdf1471-2407https://repositorio.unifesp.br/handle/11600/54124WOS:000425517300002engBmc CancerLondoninfo:eu-repo/semantics/openAccessPereira, Claudia Mariade Carvalho, Ana Carolina [UNIFESP]da Silva, Felipe RodriguesMelendez, Matias EliseoLessa, Roberta CardimAndrade, Valeria Cristina C. [UNIFESP]Kowalski, Luiz PauloVettore, Andre L. [UNIFESP]Carvalho, Andre Lopesreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T05:25:41Zoai:repositorio.unifesp.br/:11600/54124Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-11T05:25:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
title In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
spellingShingle In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
Pereira, Claudia Maria
OSCC
Gene expression
Methylation
CA3
FHL1
title_short In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
title_full In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
title_fullStr In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
title_full_unstemmed In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
title_sort In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer
author Pereira, Claudia Maria
author_facet Pereira, Claudia Maria
de Carvalho, Ana Carolina [UNIFESP]
da Silva, Felipe Rodrigues
Melendez, Matias Eliseo
Lessa, Roberta Cardim
Andrade, Valeria Cristina C. [UNIFESP]
Kowalski, Luiz Paulo
Vettore, Andre L. [UNIFESP]
Carvalho, Andre Lopes
author_role author
author2 de Carvalho, Ana Carolina [UNIFESP]
da Silva, Felipe Rodrigues
Melendez, Matias Eliseo
Lessa, Roberta Cardim
Andrade, Valeria Cristina C. [UNIFESP]
Kowalski, Luiz Paulo
Vettore, Andre L. [UNIFESP]
Carvalho, Andre Lopes
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira, Claudia Maria
de Carvalho, Ana Carolina [UNIFESP]
da Silva, Felipe Rodrigues
Melendez, Matias Eliseo
Lessa, Roberta Cardim
Andrade, Valeria Cristina C. [UNIFESP]
Kowalski, Luiz Paulo
Vettore, Andre L. [UNIFESP]
Carvalho, Andre Lopes
dc.subject.por.fl_str_mv OSCC
Gene expression
Methylation
CA3
FHL1
topic OSCC
Gene expression
Methylation
CA3
FHL1
description Background: Aberrant methylation is a frequent event in oral cancer. Methods: In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cell lines and patients' samples and confirmed using TCGA data. Differentially expressed genes were identified in ORESTES libraries and validated in vitro using RT-PCR in HNSCC cell-lines and OSCC tumor samples. Further confirmation of these results was performed using mRNA expression and methylation data from The Cancer Genome Atlas (TCGA) data. Results: From the set of genes selected for validation, CA3 and FHL1 were downregulated in 60% (12/20) and 75% (15/20) of OSCC samples, respectively, and in HNSCC cell lines. The treatment of cell lines JHU-13 and FaDu with the demethylating agent 5'-aza-dC was efficient in restoring CA3 and FHL1 expression. TCGA expression and methylation data on OSCC confirms the downregulation of these genes in OSCC samples and also suggests that expression of CA3 and FHL1 is probably regulated by methylation. The downregulation of CA3 and FHL1 observed in silico was validated in HNSCC cell lines and OSCC samples, showing the feasibility of integrating different datasets to select differentially expressed genes in silico. Conclusions: These results showed that the downregulation of CA3 and FHL1 data observed in the ORESTES libraries was validated in HNSCC cell lines and OSCC samples and in a large cohort of samples from the TCGA database. Moreover, it suggests that expression of CA3 and FHL1 could probably be regulated by methylation having an important role the oral carcinogenesis.
publishDate 2018
dc.date.none.fl_str_mv 2018
2020-07-08T13:09:40Z
2020-07-08T13:09:40Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/s12885-018-4077-3
Bmc Cancer. London, v. 18, p. -, 2018.
10.1186/s12885-018-4077-3
WOS000425517300002.pdf
1471-2407
https://repositorio.unifesp.br/handle/11600/54124
WOS:000425517300002
url http://dx.doi.org/10.1186/s12885-018-4077-3
https://repositorio.unifesp.br/handle/11600/54124
identifier_str_mv Bmc Cancer. London, v. 18, p. -, 2018.
10.1186/s12885-018-4077-3
WOS000425517300002.pdf
1471-2407
WOS:000425517300002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Bmc Cancer
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
application/pdf
dc.coverage.none.fl_str_mv London
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268316915597312